New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

It's normal for your eyes to change as you age, but these four expert-approved tips can help improve your eye health.

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

Looking at options history for Regeneron Pharmaceuticals REGN we detected 8 trades. If we consider the specifics of each ...

Across the recent three months, 5 analysts have shared their insights on Regenxbio RGNX, expressing a variety of opinions ...

Peking University researchers have developed a deep learning-based, noninvasive choroidal angiography method that enables ...

Dr. Andrew Lam – doctor, surgeon, author and storyteller extraordinaire – spoke to students at Springfield High School Nov. 1 ...